Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
Uncontrolled hemorrhage, an important cause of mortality among trauma patients, can be modeled using a standard liver laceration in a murine model. This model results in consistent blood loss, survival, and allows for testing hemostatic agents. This article provides the step-by-step process to perform this valuable model.
Uncontrolled hemorrhage is an important cause of preventable deaths among trauma patients. We have developed a murine model of uncontrolled hemorrhage via a liver laceration that results in consistent blood loss, hemodynamic alterations, and survival.
Mice undergo a standardized resection of the left-middle lobe of the liver. They are allowed to bleed without mechanical intervention. Hemostatic agents can be administered as pre-treatment or rescue therapy depending on the interest of the investigator. During the time of hemorrhage, real-time hemodynamic monitoring via a left femoral arterial line is performed. Mice are then sacrificed, blood loss is quantified, blood is collected for further analysis, and organs are harvested for analysis of injury. Experimental design is described to allow for simultaneous testing of multiple animals.
Liver hemorrhage as a model of uncontrolled hemorrhage exists in the literature, primarily in rat and porcine models. Some of these models utilize hemodynamic monitoring or quantify blood loss but lack consistency. The present model incorporates quantification of blood loss, real-time hemodynamic monitoring in a murine model that offers the advantage of using transgenic lines and a high-throughput mechanism to further investigate the pathophysiologic mechanisms in uncontrolled hemorrhage.
Trauma is the leading cause of death and disability among young people worldwide.1 Uncontrolled hemorrhage remains a leading cause of mortality among severely injured trauma patients.2 Management of the hemorrhaging trauma patient is two-fold: control of surgical bleeding, and resuscitation and replacement of lost blood.
Animal models of hemorrhagic shock have been the cornerstone in trauma research and can be used in the evaluation of the pathophysiology and treatment of traumatic/hemorrhagic shock.3,4 Shock in animal models can be achieved broadly by two methods: controlled-hemorrhage and uncontrolled-hemorrhage.5,6 Controlled-hemorrhage is performed by removal of a fixed volume of blood or by blood removal to achieve a certain blood pressure (fixed-pressure). While these models are useful in the evaluation in the mechanisms and immune alterations in hemorrhagic shock, they are not applicable to the testing of hemostatic agents and do not mimic the clinical scenario of hemorrhage following trauma. To this degree, we sought to develop a model of uncontrolled hemorrhage that would allow us to test hemostatic changes and pro-coagulant agents in a murine model. The liver is an attractive option for uncontrolled hemorrhage in part because of the dual blood supply to the liver and it is one of the most commonly injured intrabdominal organs in both blunt and penetrating trauma. Given the high clinical relevance, the liver has been utilized as a model of uncontrolled hemorrhage, most commonly in rat and porcine models but recently in primates as well.7,8,9,10,11,12 Murine models have also incorporated liver injury, such as a crush model or blunt trauma; however, these models do not result in hemorrhagic shock secondary to the liver injury.13,14
The rat and porcine models of uncontrolled liver hemorrhage, while valuable in looking at resuscitation practices and hemodynamic monitoring, are less advantageous than a murine model for various reasons such as cost, number of animals utilized, and importantly the relative lack transgenic lines available for analysis of specific cellular and molecular signaling. The present murine model shares important similarities to existing liver hemorrhage models including standardized liver laceration, blood loss quantification, hemodynamic monitoring, and the ability to perform survival analysis. Many existing models only incorporate some of these aspects whereas our model was developed to measure many of the physiologic variables simultaneously and in multiple mice. As well, development of a murine model opens the door to investigations beyond resuscitation and into greater pathophysiology mechanisms in uncontrolled hemorrhage with the potential of a cost efficient, high-throughput model using advanced molecular techniques.
Mice were housed in accordance with University of Pittsburgh (Pittsburgh, PA, USA) and National Institutes of Health (NIH; Bethesda, MD, USA) animal care guidelines in specific pathogen-free conditions with 12 h light-dark cycles and free access to standard feed and water. All animal experiments were approved and conducted in accordance with the guidelines set forth by the Animal Research and Care Committee at the University of Pittsburgh.
1. Surgical Field and Instrument Setup
2. Liver Laceration Surgical Procedure
The liver laceration model results in reproducible and consistent blood loss in mice. Figure 1A demonstrates the consistent weight of lacerated liver that can be obtained with a standard deviation of only 0.02 g. This consistency in lacerated liver weight allows the ability to reproduce the model between mice and in different experimental set-ups such as different resuscitative protocols. As well, the reproducible weight of the lacerated liver, with a standard error of on...
The murine liver laceration model described here provides a reliable, consistent model of uncontrolled hemorrhage. This model is straightforward to perform but there are important steps that require meticulous consideration. The most technically challenging part of the model is cannulation of the femoral vessels for hemodynamic monitoring and fluid/drug administration. Care must be taken during the dissection of the nerve and the arteriotomy/venotomy. It is important to not touch the nerve during the dissection of the ve...
The authors have no financial competing interests to declare.
The work of this manuscript was supported by funding to Dr. Neal by the Vascular Medicine Institute Pilot Project Program in Hemostasis and Vascular Biology (P3HVB) and the AAST Research Fellowship. This work is supported by U.S. National Institutes of Health grants 1 R35 GM119526-01 and UM1HL120877-01.
Name | Company | Catalog Number | Comments |
SS/45 dumonts | Fine Science Tools | 11203-25 | |
surgical scissors | Fine Science Tools | 14068-12 | |
hemostats | Fine Science Tools | 13009-12 | |
microscissors | Fine Science Tools | 15000-08 | |
0.8mm curved forceps | Fine Science Tools | 11009-13 | |
suture reel 6-0 | Fine Science Tools | 18020-60 | |
suture 4-0 silk w/ needle | Owens Minor | K188H | |
gauze 4x4 | can be purchased through any global vendor | ||
cotton-tip applicator | can be purchased through any global vendor | ||
30G needle | can be purchased through any global vendor | ||
23G needle | can be purchased through any global vendor | ||
10cc syringe | can be purchased through any global vendor | ||
50cc conical tube | can be purchased through any global vendor | ||
1cc syringe w/ 25G needle | Fisher Scientific | 14-826-88 | |
Polyethylene 10 tubing 100`(PE-10) | Fisher Scientific | 14-170-12P | |
Polyethylene 50 tubing 100`(PE-50) | Fisher Scientific | 14-170-12B | |
3-way stopcock | Fisher Scientific | NC9779127 | |
surgical blue pad | Fisher Scientific | 50-7105 | |
Sterile Field dressings | Fisher Scientific | NC9517505 | |
tape rolls 1" | Corporate Express | MMM26001 | |
straight side wide mouth jars | VWR | 159000-058 | |
stainless steel tray 8" x 11" | VWR | 62687-049 | |
male-male leur lock 3-way | VWR | 20068-909 | |
sterilization pouch 3"x8" | VWR | 24008 | |
sterilization pouch 5"x10" | VWR | 24010 | |
absorption triangles | Fine Science Tools | 18105-03 | |
7mm wound clip applier | Fisher Scientific | E0522687 | |
1000 7mm wound clips | Fisher Scientific | E0522687 | |
betadine (4oz) | can be purchased through any global vendor | ||
sterile gloves | can be purchased through any global vendor | ||
eppendorfs | can be purchased through any global vendor | ||
1/2cc Lo-Dose insulin syringe | Fisher Scientific | 12-826-79 | |
small weigh boat | can be purchased through any global vendor | ||
lactated ringers | can be purchased through any global vendor | ||
hepranized saline solution (.1µ hep + 9.9µNaCl) | can be purchased through any global vendor | ||
phosphate buffered saline | can be purchased through any global vendor | ||
pentobarbital | can be purchased through any global vendor | ||
Wild M650 microscope w/ boom stand | Leica | ||
Digi-Med BPA-400 analyzer & systems integrator | Micro-Med | SYS-400 | |
TXD-310 (Digi-Med Transducer) | Micro-Med | TXD-300 | |
Computer | Dell | ||
microbead instrument sterilizer | VWR | 11156-002 | |
Oster A5 clippers w. size 40 blade | VWR | 10749-020 | |
circulating heating pad 18x26 | Harvard | py872-5272 | |
rectal thermometer | Kent Scientific | RET-3 |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone